(1S,2S,4S)-2-(tert-butylamino)-4-[[4-(3,4,5-trimethoxyphenoxy)phenyl]methyl]cyclopentan-1-ol
C25H35NO5 — CID 54230597
Data last refreshed: (MolForge compound catalog, from PubChem)
About (1S,2S,4S)-2-(tert-butylamino)-4-[[4-(3,4,5-trimethoxyphenoxy)phenyl]methyl]cyclopentan-1-ol
(1S,2S,4S)-2-(tert-butylamino)-4-[[4-(3,4,5-trimethoxyphenoxy)phenyl]methyl]cyclopentan-1-ol (PubChem CID 54230597) has the molecular formula C25H35NO5 and a molecular weight of 429.56 g/mol. Its IUPAC name is (1S,2S,4S)-2-(tert-butylamino)-4-[[4-(3,4,5-trimethoxyphenoxy)phenyl]methyl]cyclopentan-1-ol.
Molecular Properties
| Compound Name | (1S,2S,4S)-2-(tert-butylamino)-4-[[4-(3,4,5-trimethoxyphenoxy)phenyl]methyl]cyclopentan-1-ol |
|---|---|
| PubChem CID | 54230597 |
| Molecular Formula | C25H35NO5 |
| Molecular Weight | 429.56 g/mol |
| Exact Mass | 429.25 |
| IUPAC Name | (1S,2S,4S)-2-(tert-butylamino)-4-[[4-(3,4,5-trimethoxyphenoxy)phenyl]methyl]cyclopentan-1-ol |
| SMILES | COc1cc(Oc2ccc(C[C@H]3C[C@H](NC(C)(C)C)[C@@H](O)C3)cc2)cc(OC)c1OC |
| InChI | InChI=1S/C25H35NO5/c1-25(2,3)26-20-12-17(13-21(20)27)11-16-7-9-18(10-8-16)31-19-14-22(28-4)24(30-6)23(15-19)29-5/h7-10,14-15,17,20-21,26-27H,11-13H2,1-6H3/t17-,20-,21-/m0/s1 |
| InChIKey | QIYYDWBNZQWRNN-YYWHXJBOSA-N |
| XLogP | 4.57 |
| TPSA | 69.18 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 429.56 |
| LogP ≤ 5 | 4.57 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 54230597 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.